Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

Scientists at Johns Hopkins University in the US have developed a new blood test that can detect signs of cancer up to three ...

Shield is the first FDA-approved blood test for primary colorectal ... that would use blood samples to detect colorectal cancers. The device detects a colon cancer secreted protein known as ...

While the previous PATHFINDER study—a prospective, year-long examination of about 6,600 people—showed that Galleri could more ...

Tiny, newly formed tumors shed small fragments of DNA that are swept into the bloodstream. Future cancer screening tests could detect them early.

Cancer research reveals blood tests can detect tumor-derived mutations years before diagnosis. Johns Hopkins scientists ...

A blood-based test has acceptable accuracy for colorectal cancer detection but not for advanced precancerous lesions in an ...

American researchers from Johns Hopkins University discovered that genetic material shed from tumors can be identified in the ...

Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Food and Drug Administration’s (FDA) ...

Let’s make June a turning point where more people get screened, more cancers are caught early and fewer lives are lost.

Such evidence can show up in a person’s blood three-and-a-half years before their cancer would be otherwise diagnosed ...